Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06276010Not ApplicableRecruiting

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Role: lead

NCT06275555Not ApplicableRecruiting

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

Role: lead

NCT06862700Recruiting

Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients

Role: lead

NCT05874700Not ApplicableUnknown

A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection

Role: lead

All 4 trials loaded